Neuroblastoma_Flashcards
What is the management approach for low-risk neuroblastoma?
The management approach for low-risk neuroblastoma includes observation (serial ultrasounds every 3-6 weeks) and possibly surgery.
What is the treatment for low-risk neuroblastoma if it progresses post-surgery?
Chemotherapy is the treatment for low-risk neuroblastoma if it progresses post-surgery.
What is the management approach for intermediate-risk neuroblastoma?
The management approach for intermediate-risk neuroblastoma includes chemotherapy and surgery.
What is the standard chemotherapy regimen for intermediate-risk neuroblastoma?
The standard chemotherapy regimen for intermediate-risk neuroblastoma includes carboplatin, etoposide, cyclophosphamide, and doxorubicin for 4-8 cycles.
What is the management approach for high-risk neuroblastoma?
The management approach for high-risk neuroblastoma includes radiotherapy, surgery, autologous bone marrow transplant, radiotherapy, immunotherapy with Dinutuximab, and isotretinoin.
What is the standard chemotherapy regimen for high-risk neuroblastoma?
The standard chemotherapy regimen for high-risk neuroblastoma includes high-dose carboplatin, etoposide, cyclophosphamide, and doxorubicin for 5-6 cycles.
What additional treatments are used for high-risk neuroblastoma?
Additional treatments for high-risk neuroblastoma include autologous bone marrow transplant, radiotherapy, immunotherapy with Dinutuximab, and isotretinoin.
What is the cure rate for children with metastatic neuroblastoma?
The cure rate for children with metastatic neuroblastoma is around 40%.
